Prasanth S. Ariyannur

About

PhD in Cancer Biology and Molecular Pathology, MD in Clinical Biochemistry after Medical Science (M.B.B.S) degree. Trained and studied biochemical, cellular, and molecular biological structures, functions, and methods over two decades. Major ones include neurochemistry, neurobiology, molecular and cellular biology of cancers, and cancer genomics. Clinical biochemistry and laboratory medicine including implementing clinical laboratory standards on ISO-15189 and CAP/CLIA standards. Molecular pathology and molecular oncology biocuration, interpretation and clinical applications of cancer multi-omics data.

Employment

• Karuna Institute of Medical Sciences Associate Professor
  2025 - Present
• Sukh Sagar Medical College and Hospital Assistant Professor
  2024 - 2025
• Karkinos Health Care Pvt Ltd Consultant and Head
  2021 - 2024
• Amrita Institute of Medical Sciences Laboratory in-Charge
  2015 - 2022
• Uniformed Services University of the Health Sciences Post Doctoral Fellow
  2011 - 2012
• Uniformed Services University of the Health Sciences Post-Doctoral Fellow
  2005 - 2011

Education

• Amrita Vishwa Vidyapeetham PhD
  2017 - 2025
• Amrita School of Medicine MD
  2016 - 2019
• Thiruvananthapuram Medical College M.B.B.S
  1996 - 2001

Projects & Funding

Projects & funding information is unavailable.

Publications (38)

• Cellular membranes as Quantum-to-Classical Transducers via 1836:1 mass-anisotropy
  2026 DOI: 10.21203/rs.3.rs-9269552/v1
  +Save
• Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer
  Molecular Oncology 2026 DOI: 10.1002/1878-0261.70108
  +Save
• The quantum-to-classical transducer: A thermodynamic and quantum mechanical framework for the emergence of bioenergetics
  BioSystems 2026 DOI: 10.1016/j.biosystems.2026.105866
  +Save
• Reconceptualizing Consciousness: Towards an Expanded Scientific Paradigm
  2025 DOI: 10.32388/CTMIP3
  +Save
• Clinical actionability of comprehensive genomic profiling in India
  Gene Reports 2025 DOI: 10.1016/j.genrep.2025.102222
  +Save
• Association of molecular subgroups with pathological parameters in endometrial carcinomas
  Indian Journal of Cancer 2024 DOI: 10.4103/ijc.IJC_13_21
  +Save
• Landscape of genomic alterations in patients with chemoradiation resistant cervical cancer using whole-genome sequencing.
  Journal of Clinical Oncology 2024 DOI: 10.1200/jco.2024.42.16_suppl.e17531
  +Save
• Molecular pathogenesis of microsatellite instability-high early-stage colorectal adenocarcinoma in India
  Drug Metabolism and Personalized Therapy 2024 DOI: 10.1515/dmpt-2024-0033
  +Save
• Therapeutic Challenges in the Management of Collecting Duct Carcinoma of the Kidney: A Case Report with Review of Literature
  Indian Journal of Medical and Paediatric Oncology 2024 DOI: 10.1055/s-0044-1791515
  +Save
• Diagnostic accuracy of MicroRNA 208b level with respect to different types of atrial fibrillation
  Indian Heart Journal 2021 DOI: 10.1016/j.ihj.2021.06.018
  +Save